**Core Concept**
Mycoplasma pneumonia is a type of atypical bacterial infection caused by Mycoplasma pneumoniae, which lacks a cell wall. This characteristic makes it resistant to beta-lactam antibiotics like penicillin and cephalosporins that target cell wall synthesis. The ideal treatment for mycoplasma pneumonia requires an antibiotic that can penetrate the cells and inhibit protein synthesis.

**Why the Correct Answer is Right**
Erythromycin is a macrolide antibiotic that effectively inhibits protein synthesis by binding to the 50S ribosomal subunit. This mechanism of action is crucial in treating mycoplasma infections, as the bacteria rely on protein synthesis for survival. Macrolides, including erythromycin, are the preferred choice for treating mycoplasma pneumonia due to their ability to penetrate the cells and inhibit protein synthesis.

**Why Each Wrong Option is Incorrect**
**Option A:** Penicillin is a beta-lactam antibiotic that targets cell wall synthesis, making it ineffective against mycoplasma bacteria that lack a cell wall.

**Option B:** Tetracycline is an antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit. However, its effectiveness against mycoplasma pneumonia is limited due to the bacteria's ability to develop resistance.

**Option C:** Cefuroxime is a cephalosporin antibiotic that also targets cell wall synthesis, making it ineffective against mycoplasma bacteria.

**Clinical Pearl / High-Yield Fact**
Macrolides, including erythromycin, are also effective against other atypical bacterial infections, such as Legionella and Chlamydia. It's essential to consider the specific causative agent and its antibiotic susceptibility pattern when treating respiratory infections.

**✓ Correct Answer: D. Erythromycin**